Testing effectiveness (Phase 2)Ended earlyNCT01338857
What this trial is testing
Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas
Who this might be right for
neurofibromatosis1 (NF1)Recurrent or Progressive Optic Pathway Gliomas (OPG)Recurrent or Progressive Low-grade Glioma
NYU Langone Health 12